‘I don’t want to tell families there aren’t any options’: Palliative care’s opioid crisis

AusDoc speaks to Dr Christine Mott, president of ANZSPM.
Sarah Simpkins
Dr Christine Mott.

Doctors have warned the Australian market will lose around 15 opioid analgesics later in the year, with one palliative paediatrician saying the alternatives may not be accessible or suitable replacements.

Recently, Mundipharma flagged that in roughly eight weeks it would be withdrawing supply of 5mg, 10mg and 20mg OxyNorm capsules (oxycodone hydrochloride); 30mg, 60mg, 90mg and 120mg MS Mono capsules (modified-release morphine sulfate), and 10mg and 20mg Sevredol tablets (morphine sulfate).